Predilation with smaller valvuloplasty balloon diameter could reduce the need for permanent pacemaker after CoreValve

Original title: Reduction of pacemaker implantation rates alter CoreValve implantation by moderate predilatation 
Reference: Philipp Lange, et al. EuroIntervention 2014;9:1151-1159

Aortic valve implantation has been proven a valid strategy to treat high risk patients. The CoreValve self-expanding transcatheter aortic valve is associated with a relatively high rate of permanent pacemaker implantation and, until now, no efforts have been made to reduce this rate.

This study included 269 consecutive patients undergoing TAVI with the CoreValve prosthesis; 32 with previously implanted permanent pacemaker were excluded and 237 patients were included in the final analysis. All patients presented severe aortic stenosis and had high surgical risk. Implantation success rate was 99.3% (236) and no patients turned to surgery. The most frequent conduction complication was complete left bundle branch block (42%).

Globally, 50 patients required permanent pacemakers (21.1%); the rate was higher in patients that received a # 29 valve (18.5% vs. 25%).  All patients received balloon valvuloplasty previous to implantation, 114 with 25 mm balloons and 123 with 23 mm balloons, where the PP implantation rate decreased (27.1% vs. 15.4% respectively; p=0.042). 

The analysis was performed according to implanted VB size (26 or 29 mm) and both groups showed lower PP rates the smaller the predilation balloon. PP requirement predictors were preexisting complete left bundle branch block, complete right bundle branch block, first degree AV block, valve high positioning and inter ventricular septal diameter.

Conclusion:

Moderate balloon predilation previous to transcatheter valve implantation with CoreValve reduces the need for permanent pacemaker without affecting procedural success.

 

Comment

The need for a permanent pacemaker after TAVI is now between 16% and 40%, depending on prosthesis size, and does not represent a complication that will modify prognosis, though it does affect procedural costs.

Balloon predilation may fracture calcified lesions, with the risk of stroke. We should measure the risk/benefit ratio for each patient when evaluating our strategy.

Courtesy of Dr. Carlos Fava.
Interventional Cardiologist
Favaloro Foundation – Buenos Aires

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...